But Is All Post-Transplant Lymphoproliferative Disorder Created Equal?
JACC Heart Fail
.
2024 Feb;12(2):406-408.
doi: 10.1016/j.jchf.2023.11.004.
Author
Maryl R Johnson
1
Affiliation
1
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Electronic address: mrj@medicine.wisc.edu.
PMID:
38326003
DOI:
10.1016/j.jchf.2023.11.004
No abstract available
Keywords:
heart transplantation; immunosuppression; post-transplant lymphoproliferative disorder.
Publication types
Editorial
MeSH terms
Heart Failure*
Humans
Immunosuppressive Agents / therapeutic use
Lymphoproliferative Disorders* / etiology
Substances
Immunosuppressive Agents